Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer immunotherapy
4
×
clinical trials
fda
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
chronic kidney disease
deals
europe blog main
europe top stories
forty seven
investing
ipo
medicare
nivolumab
What
ipo
4
×
companies
life
science
week
bio
momentum
new
raised
roundup
sciences
acquisitions
announced
arena’s
arrival
biotech
biotechs
bounty
ceo
cig
club
collabs
comeback
continued
corner
covid
crop
daniel
days
deal
deals
delivered
exceeded
expressing
firms
gilead
gilead’s
group
hasn’t
haul
Language
unset
Current search:
ipo
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M